The APAC antibody discovery market is experiencing robust expansion, fueled by a rising prevalence of chronic illnesses and a enhanced focus on personalized healthcare. Notable investment in research and development, particularly within countries like China, Japan, and East Korea, is driving the implementation of advanced antibody identification… Read More